Get started
Author

I. Komarov

Observed names: I. A. Komarov, I. A. Romashchenko V. A. Komarov, I.A. Komarov, Il'ia Aleksandrovich Komarov, Il'ya Komarov, Ilya A. Komarov, Komarov I. A., И.А. Комаров
ORCID: 0000-0002-1518-184X
Observed ORCID: 0000-0002-1518-184X
OpenAlex ID: A5003416601
Statutory regulation of subsidized pharmaceutical provision in Russian Federation
2020 · Oleg A. Nagibin, Elena V. Manukhina, et al. · I P Pavlov Russian Medical Biological Herald · 7
PDF
Prevalence and Diagnosis of Rare (orphan) Diseases in Pediatric Population of the Russian Federation
2020 · T.P. Vasilieva, R.A. Zinchenko, et al. · PEDIATRIA Journal named after G N SPERANSKY · 5
Budget Impact Analysis of Belimumab In the Treatment of Patients With Systemic Lupus Erythematosus In Russian Federation
2014 · A. Kulikov, I. Komarov, et al. · Value in Health · 4
PDF
Disability and Mortality Rates of the Child Population of the Russian Federation in Case of Rare (orphan) Diseases
2020 · R.A. Zinchenko, T.P. Vasileva, et al. · PEDIATRIA Journal named after G N SPERANSKY · 3
Pharmacoeconomic Analysis Tofacitinib Use in Rheumatoid Arthritis Treatment Scheme
2014 · A. Kulikov, I. Komarov, et al. · Value in Health · 3
Socioeconomic efficiency of neonatal screening for spinal muscular atrophy in the Russian Federation
2023 · I. A. Komarov, A. R. Malakhova, et al. · Neuromuscular Diseases · 2
PDF
Analysis of the prevalence of rare (orphan) diseases («List 24») and the dynamics of detection of children's patients in the subjects of the Russian Federation
2020 · И.А. Комаров, Е.Ю. Красильникова, et al. · Nauchno-prakticheskii zhurnal «Medicinskaia genetika» · 2
PDF
Pharmacoeconomic analysis of beyodyme (pertuzumab+ trastuzumab [set]) in the treatment of patients with her2- positive metastatic breast cancer
2015 · A.Yu. Kulikov, I.A. Komarov · Pharmacoeconomics theory and practice · 2
PDF
The analysis of detection of rare diseases not included into listings of orphan diseases with preferential medication support
2020 · Komarov I. A., Krasilnikova E. Iu., et al. · Problems of Social Hygiene Public Health and History of Medicine · 1
Pharmacoeconomic evaluation of targeted therapy in patients with systemic lupus erythematosus
2015 · A.Yu. Kulikov, I.A. Komarov, et al. · Pharmacoeconomics theory and practice · 1
PDF
Pharmacoeconomic analysis of kadcyla (trastuzumab emtansine) in the treatment of patients with her2-positive breast cancer
2015 · A.Yu. Kulikov, I.A. Komarov · Pharmacoeconomics theory and practice · 1
PDF
Pharmacoeconomic Study Over Use of Anticholinergic Bronchodilators (spiriva and Atrovent) for Treatment of Chronic Obstructive Pulmonary Disease
2015 · A. U. Kulikov, I. A. Komarov · DOAJ (DOAJ: Directory of Open Access Journals) · 1
Cost-effectiveness Analysis Over Use of Tyrosine Kinase Inhibitors (tasigna and Gleevec) for Treatment of Chronic Myeloid Leukemia in the Chronic Phase as First-line Therapy for De Novo Patients
2015 · R. I. Yagudina, A. Yu. Kulikov, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 1
Pharmacoeconomic Analysis of Axitinib as Second-Line Treatment for Metastatic Renal Cell Carcinoma
2014 · A. Kulikov, I. Komarov, et al. · Value in Health · 1
The Issues of Medicinal Support Under Highly Wasteful Nosologies. the Original Medicinal Preparations Reproduced Ones and Bio-analogues
2025 · I. A. Romashchenko V. A. Komarov · Problems of Social Hygiene Public Health and History of Medicine
PDF
Алгоритм расчета экономического влияния введения неонатального скрининга при редких заболеваниях
2024 · И.А. Комаров, О.Ю. Александрова · Бюллетень Национального научно-исследовательского института общественного здоровья имени Н. А. Семашко
Health-related Quality of Life in Children and Adults With Primary Immunodeficiencies in Russia
2024 · O.Yu. Alexandrova, E.Yu. Shukan, et al. · PEDIATRIA Journal named after G N SPERANSKY
Spinal muscular atrophy 5q. Clinical and genetic characteristics, molecular genetic diagnosis and etiopathogenetic treatment. 2nd ed.
2024 · Sergey Kucev, Sergey Nikitin, et al.
Drug maintenance financing of patients with rare diseases: changes on the regional level
2023 · Ilya A. Komarov, Elena Yu. Krasilnikova, et al. · Health Care of the Russian Federation
PDF
The rare diseases and orphan medications: Placement in health care of the Russian Federation
2023 · I. A. Komarov · Problems of Social Hygiene Public Health and History of Medicine
PDF
The characteristics of restrictive listings of medications: the position of orphan medical preparations
2022 · I. A. Komarov · Problems of Social Hygiene Public Health and History of Medicine
PDF
Analysis of the budget expenditure for rare diseases in the subjects of the Russian Federation
2022 · I. A. Komarov, E. Yu. Krasilnikova, et al. · Remedium Journal about the Russian market of medicines and medical equipment
“New” rare diseases and budget deficiency: is the problem “great”?
2022 · I. A. Komarov, E. Yu. Krasilnikova, et al. · Remedium Journal about the Russian market of medicines and medical equipment
Rare Diseases and Orphan Drugs. Limited Lists and its Formulation
2022 · Il'ia Aleksandrovich Komarov · Publishing house Sreda eBooks
Rare Diseases and Orphan Drugs. Limited Lists and its Formulation
2022 · Il'ia Aleksandrovich Komarov · Publishing house Sreda eBooks
PDF
Works count: 50
Citation count: 34
H-index: 3
I10-index:
Year
Topic
Type